Pricing Log in Create free account
Friday 6 November 2026 Export PFE’s income statement to Excel — free account

Pfizer Inc.

PFE Healthcare Drug Manufacturers General

Pfizer Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.6 billion, down 1.65% from fiscal 2024.

Revenue
−0.43%
EPS
−7.98%
Free cash flow
+20.0%
Total debt
+1.55%

Quarter to September 2026, against a year earlier

29.96 0.83 −2.70%
Market cap
$170.3B
P/E
42.2×
Fwd P/E
18.9×
Dividend yield
7.18%
F-score
6/9
Altman Z
2.03
Beneish M
−2.52
Dividend safety
28/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Pfizer Inc. (PFE) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Pfizer Inc. (PFE) trades at a EV/EBITDA of 10.9×. Over the past ten years it has ranged from 5.7× (March 2023) to 55.3× (July 2024); the current reading is higher than 30% of that period. That is below the Drug Manufacturers General industry median of 14.8× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 9.2× (7.46%)
FY2024 10.0× (66.67%)
FY2023 30.0× 307.57%
FY2022 7.4× (46.42%)
FY2021 13.7× (23.50%)
FY2020 17.9× (12.54%)
FY2019 20.5× (11.29%)
FY2018 23.1× 95.82%
FY2017 11.8× (4.17%)
FY2016 12.3× 2.21%

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 10.5× 13.25%
Jun 2026 9.3× (7.47%)
Mar 2026 10.0× 8.09%
Dec 2025 9.2× (1.45%)
43 more quarters

Against its own ten years

Low 5.7× High 55.3×
Ten-year median 12.1×
Current reading's percentile 30

EV/EBITDA against peers

Company EV/EBITDA
NVO Novo Nordisk A/S compare 7.3×
GSK GSK PLC Sponsored ADR compare 10.6×
PFE Pfizer Inc. 10.9×
BMY Bristol Myers Squibb Company compare 11.3×
SNY Sanofi compare 11.4×
AZN AstraZeneca PLC compare 14.8×
NVS Novartis AG compare 15.6×
AMGN Amgen Inc. compare 17.6×
GILD Gilead Sciences, Inc. compare 505×
Drug Manufacturers General industry median 14.8×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on PFE